INM Stock — InMed Pharmaceuticals Inc. Common Shares: Cash, EV, Pipeline

Share price

$1.36

Market cap

$7.5M

Cash

$2.2M

Enterprise value

$5.3M

Balance sheet

Cash	$2.2M
Debt	$0.0M
Net cash	$2.2M
Enterprise value	$5.3M
Basic shares	5.3M shares
Fully diluted shares	5.7M shares
Fully diluted market cap	$7.7M
Cash per share	$0.41

Cash figures as of 2026-06-30. Database snapshot: 2026-09-21.

Price history

Loading INM daily closes…

Loading price history…

Pipeline assets

INM-901

Preclinical · Active Modality: small molecule (preferential signaling agonist)

Target CB1/CB2 (also impacts PPAR signaling)

Indications

Alzheimer's disease (Preclinical)

Catalysts

— Q3 2026
— 2027

Status note Disease-modifying candidate with IND-enabling pharmacology and toxicology studies underway.

INM-089

Preclinical · Active Modality: small molecule

Target CB1/CB2

Indications

Dry age-related macular degeneration (Preclinical)

Catalysts

— Early 2027

Status note Preclinical program for dry AMD.

INM-755 (cannabinol)

Stage not disclosed · Active Modality: topical cream

Target CB1/CB2

Indications

Epidermolysis bullosa (Stage not disclosed)

Status note Cannabinol cream. Company does not currently intend to devote significant resources to advancing it; further development would require additional financing.

Per-asset detail extracted from the 10-Q filed 2026-05-06. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.

No lead program on file for this company.

No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.

Institutional holders

Fund	Shares	Q/Q change	% of portfolio	Filing
ADAR1 Capital Management	800,000	+800,000	0.06%	2026-08-14
Ikarian Capital	245,025	+245,025	0.06%	2026-08-14

Institutional holder positions from 13F filings. Q/Q change is vs the prior quarter's filing; % of portfolio is the fund's own reported portfolio weight.

INM — InMed Pharmaceuticals Inc. Common Shares

Balance sheet

Price history

Pipeline assets

Institutional holders